Precision Expression: Accelerating Complex Biotherapeutic Production In CHO Cells

Discover how an innovative cell line development platform is redefining the production of next-generation biotherapeutics. In this expert-led presentation, explore a breakthrough approach that shifts the focus from conventional genetic regulatory elements to precise control of gene copy number, enabling rapid generation of stable, high-producing CHO cell lines for even the most complex multi-gene constructs.

Learn how this advanced strategy accelerates development timelines while delivering consistently high titers, robust manufacturability, and enhanced product quality. The session will highlight how the platform overcomes common challenges associated with sophisticated biologic modalities, including antibody-drug conjugates (ADCs), bispecifics, and multi-subunit proteins, where balanced expression and cellular stability are critical.